Sugiura T, Shahannaz D, Ferrell B
Int J Mol Sci. 2024; 25(11).
PMID: 38891960
PMC: 11171475.
DOI: 10.3390/ijms25115772.
Jain S, Voulgaris D, Thongkorn S, Hesen R, Hagg A, Moslem M
Adv Sci (Weinh). 2024; 11(25):e2401859.
PMID: 38655836
PMC: 11220685.
DOI: 10.1002/advs.202401859.
Haubenreich C, Lenz M, Schuppert A, Peitz M, Koch P, Zenke M
Int J Mol Sci. 2024; 25(6).
PMID: 38542188
PMC: 10969834.
DOI: 10.3390/ijms25063214.
Yamatani Y, Nakai K
NAR Genom Bioinform. 2022; 4(4):lqac087.
PMID: 36458020
PMC: 9706419.
DOI: 10.1093/nargab/lqac087.
Zhao Q, Liu K, Zhang L, Li Z, Wang L, Cao J
Cell Death Dis. 2022; 13(11):976.
PMID: 36402748
PMC: 9675825.
DOI: 10.1038/s41419-022-05413-4.
Passage number affects differentiation of sensory neurons from human induced pluripotent stem cells.
Cantor E, Shen F, Jiang G, Tan Z, Cunningham G, Wu X
Sci Rep. 2022; 12(1):15869.
PMID: 36151116
PMC: 9508090.
DOI: 10.1038/s41598-022-19018-6.
A Comparative Study of Cell Culture Conditions during Conversion from Primed to Naive Human Pluripotent Stem Cells.
Romayor I, Herrera L, Buron M, Martin-Inaraja M, Prieto L, Etxaniz J
Biomedicines. 2022; 10(6).
PMID: 35740381
PMC: 9219795.
DOI: 10.3390/biomedicines10061358.
Bioinformatic and Genomic Analyses of Cellular Reprogramming and Direct Lineage Conversion.
Kareta M
Curr Pharmacol Rep. 2022; 2(3):103-112.
PMID: 35663262
PMC: 9165525.
DOI: 10.1007/s40495-016-0054-1.
Highly Effective Protocol for Differentiation of Induced Pluripotent Stem Cells (iPS) into Melanin-Producing Cells.
Sulkowski M, Kot M, Badyra B, Paluszkiewicz A, Plonka P, Sarna M
Int J Mol Sci. 2021; 22(23).
PMID: 34884599
PMC: 8657900.
DOI: 10.3390/ijms222312787.
A New Induction Method for the Controlled Differentiation of Human-Induced Pluripotent Stem Cells Using Frozen Sections.
Tadokoro S, Tokuyama-Toda R, Tatehara S, Ide S, Umeki H, Miyoshi K
Cells. 2021; 10(11).
PMID: 34831050
PMC: 8616214.
DOI: 10.3390/cells10112827.
The Potential of Induced Pluripotent Stem Cells to Advance the Treatment of Pancreatic Ductal Adenocarcinoma.
Krog R, de Miranda N, Vahrmeijer A, Kooreman N
Cancers (Basel). 2021; 13(22).
PMID: 34830945
PMC: 8616212.
DOI: 10.3390/cancers13225789.
PAX7 Balances the Cell Cycle Progression via Regulating Expression of and in Differentiating PSCs.
Florkowska A, Meszka I, Nowacka J, Granica M, Jablonska Z, Zawada M
Cells. 2021; 10(9).
PMID: 34571854
PMC: 8472244.
DOI: 10.3390/cells10092205.
To Better Generate Organoids, What Can We Learn From Teratomas?.
Li H, Gao L, Du J, Ma T, Ye Z, Li Z
Front Cell Dev Biol. 2021; 9:700482.
PMID: 34336851
PMC: 8324104.
DOI: 10.3389/fcell.2021.700482.
Neural Stem Cells for Early Ischemic Stroke.
Hamblin M, Lee J
Int J Mol Sci. 2021; 22(14).
PMID: 34299322
PMC: 8306669.
DOI: 10.3390/ijms22147703.
"Betwixt Mine Eye and Heart a League Is Took": The Progress of Induced Pluripotent Stem-Cell-Based Models of Dystrophin-Associated Cardiomyopathy.
Rovina D, Castiglioni E, Niro F, Mallia S, Pompilio G, Gowran A
Int J Mol Sci. 2020; 21(19).
PMID: 32977524
PMC: 7582534.
DOI: 10.3390/ijms21196997.
Pluripotent stem cells with low differentiation potential contain incompletely reprogrammed DNA replication.
Paniza T, Deshpande M, Wang N, ONeil R, Zuccaro M, Smith M
J Cell Biol. 2020; 219(9).
PMID: 32673399
PMC: 7480103.
DOI: 10.1083/jcb.201909163.
Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies.
Ramachandra C, Chua J, Cong S, Kp M, Shim W, Wu J
Cardiovasc Res. 2020; 117(3):694-711.
PMID: 32365198
PMC: 7898957.
DOI: 10.1093/cvr/cvaa125.
Transcriptomically Guided Mesendoderm Induction of Human Pluripotent Stem Cells Using a Systematically Defined Culture Scheme.
Carpenedo R, Kwon S, Tanner R, Yockell-Lelievre J, Choey C, Dore C
Stem Cell Reports. 2019; 13(6):1111-1125.
PMID: 31813826
PMC: 6915803.
DOI: 10.1016/j.stemcr.2019.11.001.
A realistic appraisal of the use of embryonic stem cell-based therapies for cardiac repair.
Wysoczynski M, Bolli R
Eur Heart J. 2019; 41(25):2397-2404.
PMID: 31778154
PMC: 7327535.
DOI: 10.1093/eurheartj/ehz787.
Overview: an iPS cell stock at CiRA.
Umekage M, Sato Y, Takasu N
Inflamm Regen. 2019; 39:17.
PMID: 31497180
PMC: 6717959.
DOI: 10.1186/s41232-019-0106-0.